Oncologist with Texas Oncology
Oncology
Dr. Linda Verkruyse, MD
|
|
Give Review
Dr. Linda Verkruyse practices Oncology. She went to University of Kansas School of Medicine. She has 1 awards "Meaningful Use Stage 1 Certification". Linda Verkruyse, MD has written publications. She has 11 publications published with PubMed. The lastest publication is: 'Palmitoyl-protein thioesterase deficiency in fibroblasts of individuals with infantile neuronal ceroid lipofuscinosis and I-cell disease.' Doctor Linda Verkruyse, MD accepts all Medicare patients.
Publications
- The effects of lysosomotropic agents on normal and INCL cells provide further evidence for the lysosomal nature of palmitoyl-protein thioesterase function.
- Once daily ganciclovir as initial pre-emptive therapy delayed until threshold CMV load > or =10000 copies/ml: a safe and effective strategy for allogeneic stem cell tr...
- Fatty acid analysis of protein-derived lipid thioesters isolated from palmitoyl-protein thioesterase-deficient cells.
- Palmitoyl-protein thioesterase deficiency in fibroblasts of individuals with infantile neuronal ceroid lipofuscinosis and I-cell disease.
- Palmitoyl-protein thioesterase and the molecular pathogenesis of infantile neuronal ceroid lipofuscinosis.
- Lipid thioesters derived from acylated proteins accumulate in infantile neuronal ceroid lipofuscinosis: correction of the defect in lymphoblasts by recombinant palmito...
- Lysosomal targeting of palmitoyl-protein thioesterase.
- Analysis of Ig H chain gene segment utilization in human fetal liver. Revisiting the "proximal utilization hypothesis".
- Molecular cloning and expression of palmitoyl-protein thioesterase.
- Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis.
Schools
University Of Texas Southwestern Medical
University of Kansas School of Medicine
Procedures Preformed
- Plasmapheresis
- Thoracentesis
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
Education
-
Washington University -
University of Kansas School of Medicine -
University of Texas Southwestern Medical School
Hospital
-
Medical Center Arlington
Drug Facts
| NPI NUMBER | 1700825155 | |
| NPPES Provider LastName | VERKRUYSE | |
| NPPES Provider FirstName | LINDA | |
| NPPES Provider ZIPCode | 760142083 | |
| NPPES Provider State | TX | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 1045.0 | |
| Distinct Opioid Count | 4.0 | |
| Opioid Claim Count | 172.0 | |
| Percent Opioid Claims | 16.46 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1700825155 |
| Last Name Of The Provider | VERKRUYSE |
| First Name Of The Provider | LINDA |
| View All |
Similar Doctors
|
Dr. Rakesh K. Saini, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Shrinivas M. Diggikar, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Charles J. Deur, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anwar Khurshid, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott L. Fleischauer, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Lixin Liao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karel A. Dicke, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John W. Adams, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George R. Blumenschein Sr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alfred Di Stefano, MD
This Doctor is OpenDoctor Recommended.
|